Business Development Experience






















Acquisition/mergers

Key member of:

Millennium team for evaluation, negotiation, and subsequent integration of Cor Therapeutics merger


Millennium team negotiating divestment of INTEGRILIN


Millennium team evaluating Celgene, The Medicines Company, Esperion, Scios, CV Therapeutics, Corgentech, Encysive, Ventavis, Cotherix and Genentech TNKase/Activase line


Merck Coordinated Pharmaceutical Care (CPC) team acquiring Sysdeco, a Swedish Clinical Decision Support Software provider (subsequently served as Chairman)


Medical Marketing Group team evaluating and negotiating acquisition by Merck

Integration team following acquisition of Medco by Merck


Medco team acquiring physician prescribing software from Vectis


Medco Behavioral Care Corporation team acquiring and ultimately managing Control Diabetes Services (CDS)


MEDED team evaluating merger with Medical Marketing Group


MEDED team evaluating acquisition of IN VIVO publication from The Wilkerson Group

Ayerst team evaluating and analyzing American Home Products acquisition of A.H. Robins


Business start-up

Geppetto Avatars, Inc. in capacity of CBO


SciFluor Life Sciences, LLC, in capacity of CEO


Heartscape technologies,Inc. in capacity of CEO


MEDED Canada (in capacity of US CEO with Canadian President of subsidiary)


Marketing partnerships

Key member of leadership and governance team for Millennium-Schering-Plough US co-marketing of INTEGRILIN


Negotiated and managed GSK deal for INTEGRILIN marketing rights for European market


Senior leadership role on MSD (Merck) UK Coordinated Pharmaceutical Care (CPC) partnership with Reuters


Managed MSD (Merck) France CPC merger with Cider Sante´ (clinical software provider)


Key member of Merck-Medco team conceptualizing, negotiating and implementing Medco disease programs with Wyeth-Ayerst (JV-women’s health), Pfizer (depression), Schering-Plough (asthma, hepatitis), Eli Lilly (diabetes), Boehringer-Ingelheim (COPD), and Astra-Merck (GI disease)


Key member of Merck-Medco team negotiating broad disease management and clinical development alliance between Medco, Merck and Glaxo (not finalized)


Negotiated J & J-Merck partnership with Medco for smoking cessation program implementation through Medco mail service pharmacies


Negotiated Medco partnership with American Home Products Whitehall-Robins division for Advil patient education program


Negotiated case management relationships for Medco with Health Care Compare and Med-E-Systems/Advance MD


CLICK FOR NEXT PAGE